The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis
Open accessAbstract
Background: Low‐grade endometrial stromal sarcoma (LG‐ESS) is a rare tumor that lacks a prognostic prediction model. Our study aimed to develop a nomogram to predict overall survival of LG‐ESS patients. Methods: A total of 1172 patients confirmed to have LG‐ESS between 1988 and 2015 were selected from the Surveillance, Epidemiology and End Results (SEER) database. They were further divided into a training cohort and a validation cohort. The Akaike information criterion was used to select variables for the nomogram. The discrimination and calibration of the nomogram were evaluated using concordance index (C‐index), area under time‐dependent receiver operating characteristic curve (time‐dependent AUC), and calibration plots. The net benefits of the nomogram at different threshold probabilities were quantified and compared with those of the International Federation of Gynecology and Obstetrics (FIGO) criteria‐based tumor staging using decision curve analysis (DCA). Net reclassification index (NRI) and integrated discrimination improvement (IDI) were also used to compare the nomogram's clinical utility with that of the FIGO criteria‐based tumor staging. The risk stratifications of the nomogram and the FIGO criteria‐based tumor staging were compared. Results: Seven variables were selected to establish the nomogram for LG‐ESS. The C‐index (0.814 for the training cohort and 0.837 for the validation cohort) and the time‐dependent AUC (> 0.7) indicated satisfactory discriminative ability of the nomogram. The calibration plots showed favorable consistency between the prediction of the nomogram and actual observations in both the training and validation cohorts. The NRI values (training cohort: 0.271 for 5‐year and 0.433 for 10‐year OS prediction; validation cohort: 0.310 for 5‐year and 0.383 for 10‐year OS prediction) and IDI (training cohort: 0.146 for 5‐year and 0.185 for 10‐year OS prediction; validation cohort: 0.177 for 5‐year and 0.191 for 10‐year OS prediction) indicated that the established nomogram performed significantly better than the FIGO criteria‐based tumor staging alone ( P < 0.05). Furthermore, DCA showed that the nomogram was clinically useful and had better discriminative ability to recognize patients at high risk than the FIGO criteria‐based tumor staging. Conclusions: A prognostic nomogram was developed and validated to assist clinicians in evaluating prognosis of LG‐ESS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
Nomograms in oncology: more than meets the eye
Balachandran, V. P., Gonen, M., Smith, J. J., & DeMatteo, R. P. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71116-7 · Cited by 3,292
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Fitzgerald, M., Saville, B. R., & Lewis, R. J. (2015) · JAMA · doi:10.1001/jama.2015.37 · Cited by 787
Norris, H. J., & Taylor, H. B. (1966) · Cancer · doi:10.1002/1097-0142(196606)19:6<755::aid-cncr2820190604>3.0.co;2-u · Cited by 403
Uno, H., Tian, L., Cai, T., Kohane, I. S., & Wei, L. J. (2013) · Statistics in Medicine · doi:10.1002/sim.5647 · Cited by 385
Hosh, M., Antar, S., Nazzal, A., Warda, M., Gibreel, A., & Refky, B. (2016) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000720 · Cited by 219
Endometrial Stromal Tumors: The New WHO Classification
Conklin, C. M. J., & Longacre, T. A. (2014) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000046 · Cited by 181
Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study
Seagle, B.-L. L., Shilpi, A., Buchanan, S., Goodman, C. R., & Shahabi, S. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.05.036 · Cited by 133
Endometrial stromal tumours revisited: an update based on the 2014 WHO classification
Ali, R. H., & Rouzbahman, M. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202829 · Cited by 120
Yoon, A., Park, J., Park, J.-Y., Lee, Y.-Y., Kim, T., Choi, C. H., Bae, D., Kim, B., Lee, Y.-Y., & Nam, J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.10.029 · Cited by 72
Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
Wan, G., Gao, F., Chen, J., Li, Y., Geng, M., Sun, L., Liu, Y., Liu, H., Yang, X. F., Wang, R., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3062-6 · Cited by 64
Kong, J., Zheng, J., Cai, J., Wu, S., Diao, X., Xie, W., Chen, X., Liao, C., Yu, H., Fan, X., et al. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0426-0 · Cited by 55
Pu, N., Li, J., Xu, Y., Lee, W., Fang, Y., Han, X., Zhao, G., Zhang, L., Nuerxiati, A., Yin, H., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s157940 · Cited by 52
Significance of lymph node metastasis on survival of women with uterine adenosarcoma
Machida, H., Nathenson, M. J., Takiuchi, T., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.01.012 · Cited by 47
Song, K., Song, J., Chen, F., Lin, K., Ma, X., & Jiang, J. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.09.012 · Cited by 46
Nomogram for predicting the survival of patients with malignant melanoma: A population analysis
Yang, J., Pan, Z., Zhou, Q., Liu, Q., Zhao, F., Feng, X., & Lyu, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10720 · Cited by 36
Marital status and the incidence of sarcomas of the uterus.
Schwartz, S. M., & Weiss, N. S. (1990) · PubMed · Cited by 11
Metadata
- Authors
- Wu, J., Zhang, H., Li, L., Hu, M., Chen, L., Xu, B., & Song, Q.
- Venue
- Cancer Communications
- Published
- 2020-06-18
- Volume
- 40
- Issue
- 7
- Pages
- 301-312
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W3035957926
- Cited by
- 556
- References
- 21
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.